Accès à distance ? S'identifier sur le proxy UCLouvain
A stratified phase II study of cetuximab for the treatment of recurrent glioblastorna multiforme: Preliminary results.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Présentation orale avec comité de sélection |
|---|---|
| Access type | Accès interdit |
| Publication date | 2006 |
| Language | Anglais |
| Conference | "42nd Annual Meeting of the American-Society-of-Clinical-Oncology", (USA) Atlant, Georgiaa (du 02/06/2006 au 06/06/2006) |
| Journal information | "Journal of Clinical Oncology" - Vol. 24, no. 18S, p. 1558 (2006) |
| Peer reviewed | yes |
| issn | 0732-183X |
| e-issn | 1527-7755 |
| Publisher | American Society of Clinical Oncology ((United States) Alexandria) |
| Publication status | Publié |
| Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Unité d'oncologie médicale UCL - (SLuc) Centre du cancer |
| Links |
| Bibliographic reference | Sadones, Jan ; Chaskis, Cristo ; Joosens, Eric J. ; Dhondt, Lionel A. ; Baurain, Jean-François ; et. al. A stratified phase II study of cetuximab for the treatment of recurrent glioblastorna multiforme: Preliminary results..42nd Annual Meeting of the American-Society-of-Clinical-Oncology ((USA) Atlant, Georgiaa, du 02/06/2006 au 06/06/2006). In: Journal of Clinical Oncology, Vol. 24, no. 18S, p. 1558 (2006) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59893 |